Φορτώνει......
Profile of a Novel Anionic Fluoroquinolone—Delafloxacin
Fluoroquinolones have been in clinical use for over 50 years with significant efficacy. However, increasing resistance and emergence of some marked adverse events have limited their usage. The most recently approved class member, delafloxacin, is the only available anionic (non-zwitterionic) fluoroq...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Clin Infect Dis |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Oxford University Press
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452001/ https://ncbi.nlm.nih.gov/pubmed/30957164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy1079 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|